Jazz Pharmaceuticals PLC (JAZZ)
Net profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 414,832 | -224,060 | -329,668 | 238,616 | 523,367 |
Revenue | US$ in thousands | 3,809,840 | 3,569,430 | 2,999,690 | 2,284,420 | 2,097,480 |
Net profit margin | 10.89% | -6.28% | -10.99% | 10.45% | 24.95% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $414,832K ÷ $3,809,840K
= 10.89%
The net profit margin of Jazz Pharmaceuticals plc has fluctuated significantly over the past five years, ranging from -10.65% in 2021 to 24.21% in 2019. A negative net profit margin in 2021 and 2022 indicates that the company incurred losses during those years. The return to profitability in 2023 with a net profit margin of 10.82% is a positive sign for the company's financial performance. However, it is important to further investigate the factors contributing to these fluctuations in order to assess the company's overall profitability and financial health.
Peer comparison
Dec 31, 2023
Company name
Symbol
Net profit margin
Jazz Pharmaceuticals PLC
JAZZ
10.89%
Abbott Laboratories
ABT
14.51%
AbbVie Inc
ABBV
8.95%
Alkermes Plc
ALKS
21.69%
Amphastar P
AMPH
21.34%
ANI Pharmaceuticals Inc
ANIP
4.13%
Arcus Biosciences Inc
RCUS
-262.39%
Biomarin Pharmaceutical Inc
BMRN
7.06%
Bristol-Myers Squibb Company
BMY
17.83%
Catalent Inc
CTLT
-23.81%
Catalyst Pharmaceuticals Inc
CPRX
17.93%